Susan Drexler
2021
In 2021, Susan Drexler earned a total compensation of $368.5K as Former SVP and Chief Financial Officer at Harmony Biosciences Holdings.
Compensation breakdown
| Salary | $83,103 |
|---|---|
| Other | $285,446 |
| Total | $368,549 |
Drexler received $285.4K in other compensation, accounting for 77% of the total pay in 2021.
Drexler also received $83.1K in salary.
Rankings
In 2021, Susan Drexler's compensation ranked 11,310th out of 12,415 executives tracked by ExecPay. In other words, Drexler earned more than 8.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,310 out of 12,415 | 9th |
Division Manufacturing | 5,000 out of 5,505 | 9th |
Major group Chemicals And Allied Products | 2,215 out of 2,375 | 7th |
Industry group Drugs | 1,969 out of 2,096 | 6th |
Industry Pharmaceutical Preparations | 1,460 out of 1,546 | 6th |
Source: SEC filing on April 8, 2022.
Drexler's colleagues
We found five more compensation records of executives who worked with Susan Drexler at Harmony Biosciences Holdings in 2021.
2021
Sandip Kapadia
Harmony Biosciences Holdings
Chief Financial Officer
2021
Jeffrey Dierks
Harmony Biosciences Holdings
EVP and Chief Commercial Officer
2021
John Jacobs
Harmony Biosciences Holdings
Chief Executive Officer
2021
Jeffrey Dayno
Harmony Biosciences Holdings
Chief Medical Officer
2021
Andrew Serafin
Harmony Biosciences Holdings